journal article·2021-07-01

Engineering the fate and function of human T-Cells via 3D bioprinting

Zhizhong Jin, Xinda Li, Xinzhi Zhang, Paul DeSousa, Tao Xu, Anhua Wu

Biofabrication· Volume 13· Issue 3
Publisher page

Abstract

Abstract T-cell immunotherapy holds promise for the treatment of cancer, infection, and autoimmune diseases. Nevertheless, T-cell therapy is limited by low cell expansion efficiency ex vivo and functional deficits. Here we describe two 3D bioprinting systems made by different biomaterials that mimic the in vivo formation of natural lymph vessels and lymph nodes which modulate T-cell with distinct fates and functions. We observe that coaxial alginate fibers promote T-cell expansion, less exhausted and enable CD4 + T-cell differentiation into central memory-like phenotype (Tcm), CD8 + T-cells differentiation into effector memory subsets (Tem), while alginate-gelatin scaffolds bring T-cells into a relatively resting state. Both of the two bioprinting methods are strikingly different from a standard suspension system. The former bioprinting method yields a new system for T-cell therapy and the latter method can be useful for making an immune-chip to elucidate links between immune response and disease.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: CAR-T cell therapy research · 3D Printing in Biomedical Research · Immunotherapy and Immune Responses

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (34)

Show source-provided references
1. An overview of the immune system10.1016/S0140-6736(00)04904-7 ↗
2. Pre-treatment neutrophil-to-lymphocyte ratio is associated with neutrophil and T-cell infiltration and predicts clinical outcome in patients with glioblastoma10.1186/s12885-015-1629-7 ↗
3. CD19 CAR-T cells of defined CD4+: CD8+composition in adult B cell ALL patients10.1172/JCI85309 ↗
4. Tisagenlecleucel in children and young adults with B-cell lymphoblastic leukemia10.1056/NEJMoa1709866 ↗
5. CAR T cell therapy for solid tumors10.1146/annurev-med-062315-120245 ↗
6. Advances in 3D cell culture technologies enabling tissue-like structures to be created in vitro10.1111/joa.12257 ↗
7. Artificial 3D culture systems for T cell expansion10.1021/acsomega.8b00521 ↗
8. Scaffolds that mimic antigen-presenting cells enable ex vivo expansion of primary T cells10.1038/nbt.4047 ↗
9. 3D bioprinted glioma stem cells for brain tumor model and applications of drug susceptibility10.1088/1758-5090/8/4/045005 ↗
10. A comparative study of the behavior of neural progenitor cells in extrusion-based in vitro hydrogel models10.1088/1748-605X/ab3b4b ↗
11. Biopolymer implants enhance the efficacy of adoptive T-cell therapy10.1038/nbt.3104 ↗
12. Biopolymers codelivering engineered T cells and STING agonists can eliminate heterogeneous tumors10.1172/JCI87624 ↗
13. Cytokine secreting microparticles engineer the fate and the effect functions of T-cells10.1002/adma.201703178 ↗
14. Bioprinting three-dimensional cell-laden tissue constructs with controllable degradation10.1038/srep24474 ↗
15. Evaluation of an alginate-gelatine crosslinked hydrogel for bioplotting10.1088/1758-5090/7/2/025001 ↗
16. Rethinking lymphatic vessels and antitumor immunity10.1016/j.trecan.2016.09.005 ↗
17. Metre-long cell-laden microfibres exhibit tissue morphologies and functions10.1038/nmat3606 ↗
19. Cytokine-induced survival of activated T cells in vitro in vivo10.1073/pnas.95.7.3810 ↗
20. Efficient homing of T cells via afferent lymphatics requires mechanical arrest and integrin-supported chemokine guidance10.1038/s41467-020-14921-w ↗
21. Activation-induced cell death in T cells10.1034/j.1600-065X.2003.00051.x ↗
22. Critical role for BIM in T cell receptor restimulation-induced death10.1186/1745-6150-3-34 ↗
23. The roles of resident, central and effector memory CD4 T-cells in protective immunity following infection or vaccination10.1111/imm.12929 ↗
24. Different patterns of peripheral migration by memory CD4+ and CD8+ T cells10.1038/nature10339 ↗
25. Hyaluronan synthesis is necessary for autoreactive T-cell trafficking, activation, and Th1 polarization10.1073/pnas.1525086113 ↗
26. Selective expression of the interleukin 7 receptor identifies effector CD8 T cells that give rise to long-lived memory cells10.1038/ni1009 ↗
27. The memory of a killer T cell: models of CD8(+) T cell differentiation10.1038/icb.2015.118 ↗
28. CD8 T cell exhaustion in chronic infection and cancer: opportunities for interventions10.1146/annurev-med-012017-043208 ↗
29. T cell exhaustion: from pathophysiological basics to tumor immunotherapy10.1186/s12964-016-0160-z ↗
30. Insight into the divergent role of TRAIL in non-neoplastic neurological diseases10.1111/jcmm.15757 ↗
31. Secondary replicative function of CD8+ T cells that had developed an effector phenotype10.1126/science.1166831 ↗
32. Granzyme B: a natural born killer10.1034/j.1600-065X.2003.00044.x ↗
33. Shedded neuronal ICAM-5 suppresses T-cell activation10.1182/blood-2007-09-111179 ↗
34. ADAM12 is a costimulatory molecule that determines Th1 cell fate and mediates tissue inflammation10.1038/s41423-020-0486-8 ↗